Jeff Chamberlain

Scientific Advisor at Myosana Therapeutics

Jeff is an internationally recognized leader in the gene therapy and muscular dystrophy fields and has been a pioneer in AAV micro-Dystrophin gene therapy research and clinical development for DMD.


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices